Extensive studies of primary tumors and tumor derived cell lines revealed that inappropriate activation of speci®c STATs (particularly of STAT3 and STAT5) occurs with high frequency in a wide variety of human cancers. We reported recently that the melanoma inducing EGFRrelated receptor Xmrk speci®cally induces constitutive activation of STAT5 in ®sh melanoma cells. However, little is known about the role of STAT5 in solid tumours in general and its function in melanoma in particular. Recent examinations suggest that activated STAT signalling participates in oncogenesis by stimulating cell proliferation and preventing apoptosis. As an initial approach to understanding the consequences of Xmrk induced STAT5 signalling we used the well characterized pro B-cell line Ba/F3 as a sensitive system to analyse mitogenic as well as anti-apoptotic signalling. We identi®ed STAT5 activation as being involved in both growth and survival signalling triggered by the Xmrk kinase possibly due to STAT5 induced expression of pim-1 and bcl-x. We also found a new mechanism of activation of STAT5 by receptor tyrosine kinases, whereby direct interaction of the receptor kinase domain with the STAT protein in a phosphotyrosine independent way led to activation of STAT5 in terms of DNA binding and target gene expression.
Introduction
STATs (signal transducers and activators of transcription) are cytoplasmic proteins, which dimerize after tyrosine phosphorylation and translocate into the nucleus, where they act as transcription factors. The tyrosine phosphorylation and thus activation can be mediated by receptor tryrosine kinases (RTKs) and besides STAT1 and STAT3, STAT5 was found to be involved in the signalling of RTKs such as the EGF and PDGF receptor (David et al., 1996; Vignais et al., 1996) . However, apart from its activation through RTKs, STAT5 is playing its major role in the signal transduction of cytokine receptors such as the prolactin, the IL-2-, the IL-3-, the growth hormone and the erythropoietin receptor (Bowman et al., 2000; Pallard et al., 1995) . The fact that STAT5 activity is controlled by this wide range of cytokines and growth factors suggests an important role of this protein in the regulation of cell dierentiation and cell growth. However, in addition to its central role in normal cell signalling, various studies have demonstrated that constitutively-activated STAT5 signalling directly contributes to oncogenesis (Bowman et al., 2000) .
We have shown recently that the melanoma inducing receptor tyrosine kinase Xmrk (Xiphophorus melanoma receptor kinase) speci®cally activates STAT5 but not STAT1 and STAT3 in melanoma cells (Baudler et al., 1999) and that constitutive STAT5 signalling correlates with the malignancy of melanomas of the ®sh Xiphophorus (Wellbrock et al., 1998) . Xmrk belongs to the EGFR family and represents an additional member to the four widely expressed receptors EGFR, HER2, 3 and 4. In Xiphophorus, overexpression of Xmrk is the initiator of melanoma formation (Wittbrodt et al., 1989) , but cell-type speci®c manifestation of the transformed state is due to a Xmrk speci®c intracellular signalling (Winkler et al., 1994) . This signalling involves recruitment and activation of the adaptor proteins Shc and GRB2 (Wellbrock and Schartl, 1999) , the src kinase p59 fyn and Phosphatidylinositol-3 kinase (PI3K) (Wellbrock and Schartl, 2000) as well as STAT5 (Wellbrock et al., 1998) . However, although it was shown that PI3K, fyn and activation of the MAP kinase pathway through GRB2 contribute to mitogenic signalling in ®sh melanoma cells, nothing is known about the role of STAT5 in Xmrk triggered cell transformation.
Since STAT5 is playing an essential role in signal transduction of cytokine receptors, extensive studies on its functional role in intracellular signalling were done in the IL-3 dependent pro B cell line Ba/F3. The same cell line was used to investigate speci®c signalling of members of the EGFR family, which led to the ®nding that the EGFR is not able to mediate long-term growth in Ba/F3 cells due to the inability to complete cell division (Riese et al., 1996a; Shibuya et al., 1992) . We used this well characterized cell line to examine, whether the Xmrk kinase can trigger survival and proliferation signals through the STAT5 pathway, since STAT5 is an eective`growth mediator' in Ba/ F3 cells (Nosaka et al., 1999) . Indeed, we found that the Xmrk kinase in contrast to the EGFR can mediate long-term proliferation in Ba/F3 cells. Analysis of truncated receptor mutants and comparison with the inecient EGFR signalling in this cell system led to identi®cation of STAT5 as a relevant factor for both the survival and growth eect mediated by the melanoma inducing kinase.
Results

HER-mrk in contrast to EGFR suppresses apoptosis and mediates long-term growth in Ba/F3 cells
Earlier we have shown that activation of the Xmrk kinase in a chimeric Xmrk-receptor (HER-mrk), when expressed in BaF/3 cells (BaF Hm cells) leads to induction of DNA synthesis (Wellbrock et al., 1998) . In contrast, Ba/F3 cells expressing the closely related EGFR (BaF HER cells) showed no signi®cant induction of DNA synthesis (Figure 1a) , which is in agreement with reported data (Shibuya et al., 1992) . The dierence between the two receptors was also seen in long-term growth experiments. Whereas the EGFR was inecient in inducing this cellular response in dierent BaF HER clones (HER 3, 5, 6) activation of HER-mrk resulted in long-term proliferation in various BaF Hm clones (Hm 2, 4, 9) ( Figure 1b) . Since Ba/F3 cells lack endogenous expression of all EGFR family members (Riese et al., 1995) , this demonstrates that the HER-mrk receptor is able to trigger all signals necessary for ecient growth in this cell system as a homodimer. This is striking since it was shown that all other members of the EGFR family are not sucient to induce this response as homodimers (Riese et al., 1995 (Riese et al., , 1996a .
Long-term growth in Ba/F3 cells is not only dependent on proliferative signals but also on signals suppressing apoptosis, which is induced by IL-3 withdrawal. Therefore, we examined the capacity of the two receptors to suppress apoptosis in Ba/F3 cells by analysing DNA fragmentation. In contrast to EGFR, HER-mrk was very ecient in suppressing apoptosis when cells were kept under EGF for 20 h after IL-3 withdrawal (Figure 1c) . These experiments were done for all clones, which behaved similarly (data not shown). Clones BaF Hm9 and BaF HER3 were chosen for further studies and will be referred to as BaF Hm and BaF HER.
HER-mrk but not the EGFR activates STAT5 in Ba/F3 cells
To identify the signalling pathways responsible for the dierences in the physiological response of BaF Hm and BaF HER cells we examined the activation of PI3-kinase (Figure 2a) , the MAP kinase pathway ( Figure  2b ) and STAT5 ( Figure 2c ) by both the EGFR and the HER-mrk receptor, since it is known that these (Kinoshita et al., 1997; Rosa Santos et al., 2000) . Activation of the catalytic activity of PI3-kinase was signi®cantly increased after stimulation of the HERmrk receptor as well as of the EGFR indicated by serine phosphorylation of Akt (Figure 2a ), a protein acting further downstream in the PI3-kinase signalling pathway. Also MAP kinase phosphorylation detectable with anti-phospho MAPK was observed after stimulation of HER-mrk and the EGFR, although the intensity of the signal was lower for the EGFR stimulation (Figure 2b ). To investigate if the receptors were able to activate STAT5, its DNA binding activity after receptor stimulation was measured. Cell extracts of BaF Hm and BaF HER cells were incubated with a multimerized oligonucleotide containing a STAT5 binding site (Pallard et al., 1995) and bound proteins were analysed by immunoblotting with anti-STAT5. Stimulation of HER-mrk induced activation and DNA binding of STAT5 whereas no DNA binding activity was found in extracts from untreated cells (Figure 2c With the aim to dissect mitogenic from anti-apoptotic signalling induced by the intracellular part of the Xmrk receptor we generated Ba/F3 cell lines expressing receptor versions either with a truncated carboxyterminus (Hm D702, D1006, D1075, D1153) or lacking the kinase domain (Dkin, Figure 3a) . The receptor mutants were constructed such that the carboxytermini contained an increasing number of both putative and already de®ned substrate binding phosphotyrosine residues. Whereas Hm D1006 possesses no tyrosine which will be phosphorylated after receptor stimulation, Hm D1075 contains a binding site for the adaptor protein GRB2 and Hm D1153 contains major binding sites for the src kinase fyn and the adaptor protein Shc in addition (Wellbrock and Schartl, 1999) . Clones expressing similar amounts of receptors were chosen for further analyses.
To verify, that the expressed receptor mutants were functional, we analysed both receptor autophosphorylation as well as the intracellular substrate phosphorylation in response to EGF. Stimulation of the fulllength HER-mrk, the Hm D1153 and the Hm D1075 receptor led to a similar degree of autophosphorylation and they could be detected as 165, 160 and 145 kD phosphotyrosine proteins respectively ( Figure 3b ). In addition Hm D1075, Hm D1153 and full-length HERmrk induced phosphorylation of a 52 kD and a 90 kD protein. Reprobing of the blot with the respective antibodies con®rmed data from earlier studies (Wellbrock and Schartl, 1999 ) that the 52 kD protein represents Shc and the 90 kD protein STAT5 (data not shown). Neither receptor nor intracellular substrate phosphorylation was seen after EGF treatment of the D702 and Dkin receptor variants. Also Hm D1006, as expected, showed no receptor phosphorylation due to the lack of the relevant tyrosine residues, but, surprisingly, phosphorylation of intracellular proteins, was detected after stimulation with EGF. Together these data show that all receptor variants possessing a The long-term growth analysis of receptor expressing cell lines in response to EGF revealed that both receptor versions lacking an active kinase domain (D702 and Dkin) were inecient in cellular signalling and the cell number rapidly decreased with almost no living cell after 4 days ( Figure 4a ). The number of wild type and Hm D1006 expressing cells was stable up to 4 days and then decreased to zero after 7 days ( Figure 4a ). In contrast, cells expressing Hm D1153 or D1075 grew as eciently in the presence of EGF as cells expressing the full-length HER-mrk receptor (Figure 4b ), indicating that the binding sites present between amino acids 1006 and 1075 of the receptor are sucient to trigger cellular signalling leading to long-term growth.
The potency of the receptors to induce mitogenesis was measured by 3 H-thymidine incorporation. As expected the D702 and the Dkin mutants showed no DNA synthesis after stimulation with EGF, whereas HER-mrk, D1075 and D1153 led to ecient cell cycle progression ( Figure 4d) . Surprisingly, also Hm D1006 was able to stimulate DNA synthesis and was almost as potent as Hm 1075. Since this receptor variant cannot induce long-term proliferation we wondered, whether it was able to suppress apoptosis after IL3-withdrawal. After 20 h of EGF stimulation of BaF Hm D1006 the detection of DNA degradation clearly showed that Hm D1006 was not sucient to suppress apoptosis in Ba/F3 cells in the absence of IL-3 ( Figure  4e) . Thus, the fact that Hm D1006 induced cell cycle progression but was inecient in suppression of apotosis enabled us to distinguish between pathways needed for mitogenic signalling and pathways essential for survival. In order to identify the pathways related with the dierent cellular responses, we next compared signalling of the Hm D1006 receptor version to signalling of Hm D1075 or HER-mrk, which were able to mediate long-term growth.
Activation of MAP kinase is dependent on carboxyterminal phosphotyrosine residues
Activation of MAP kinase was determined after EGF stimulation using anti phospho-MAPK. HER-mrk and Hm D1075 induced strong phosphorylation of MAP kinase after EGF stimulation ( Figure 5 ). Only Hm D1006 and Hm Dkin were inecient in activating the MAP kinase pathway which is in accordance with their inability to phosphorylate Shc (see Figure 3 ) and shows that for induction of the MAP kinase pathway not only an intact kinase domain but also carboxyterminal residues in the mrk intracellular part are essential.
STAT5 binds to HER-mrk in a phosphotyrosine independent way and can be directly activated by the mrk kinase domain Like HER-mrk, Hm D1075 as well as Hm D1006 induced DNA binding of STAT5 after stimulation with EGF (Figure 6a ), but, whereas Hm D1075 was as ecient as the full-length HER-mrk receptor, stimulation of Hm D1006 only led to approximately half the amount of DNA bound STAT5. However, immunouorescence analysis revealed that stimulation of Hm D1006 with EGF induced nuclear translocation of STAT5 almost as intensely as it was caused by the HER-mrk receptor (Figure 6b) .
The fact that Hm D1006 could induce activation of STAT5 pointed to an interaction of the receptor and the STAT protein without involvement of carboxyterminal phosphotyrosine residues. This was veri®ed by coimmunoprecipitation experiments. Tyrosine phosphorylation of STAT5 by HER-mrk was only detectable after receptor stimulation (Figure 6c ), however the STAT protein was identi®ed in HERmrk immunoprecipitates from unstimulated as well as from stimulated cells (Figure 6d ) indicating that it is constitutively associated with HER-mrk. The independency of STAT5 association on carboxyterminal sequences of HER-mrk was con®rmed by co-immuno- (Figure 6d) . Nevertheless, carboxyterminal residues seem to be needed for full activation of STAT5, which is re¯ected in the stronger response after stimulation of Hm D1075 (Figure 6a ).
HER-mrk but not the EGFR induces expression of pim-1, bcl-x and c-myc in Ba/F3 cells Functional signalling of STAT5 was examined by analysis of STAT5 target gene induction upon EGF stimulation. According to their capability to activate STAT5, the receptors induced expression of cis and pim-1, a serinekinase involved in mitogenic signalling in Ba/F3 cells (Nosaka et al., 1999) . No transcripts were detectable after stimulation of the EGFR, whereas Hm D1006 and Hm D1075 like the full-length HER-mrk receptor induced expression of cis as well as of pim-1 (Figure 7a ), which matches their ability to trigger cell cycle progression.
A target gene of STAT5, encoding an anti-apoptotic protein of the Bcl-2 family is bcl-x (Dumon et al., 1999) . Bcl-x expression was induced after stimulation of full-length HER-mrk and Hm D1075, whereas no upregulation of the bcl-x transcript was detectable after stimulation of the EGFR (Figure 7b ). Also Hm D1006 induced bcl-x expression although much weaker.
In addition to STAT5 target genes we analysed cmyc induction, since it is known to be a positive regulator of proliferation but not involved in anti- Values are normalized to the response to IL-3 stimulation (100%). Error bars show the (+) standard deviation from at least four determinations. (e) BaF Hm and BaF Hm D1006 cells were IL-3 deprived for 2 h and then kept for further 20 h in the presence of the indicated factors before genomic DNA was isolated and analysed for fragmentation on an agarose gel Figure 5 Hm D1006 fails to induce MAPK activation. Cells expressing the dierent receptor variants were stimulated with EGF for 10 min (+) or left untreated. Cellular lysates were analysed on a Western blot using anti-pthospho MAPK and after stripping the membrane using anti-ERK2 apoptotic signalling in Ba/F3 cells (Kinoshita et al., 1995; Nosaka et al., 1999; Shibuya et al., 1992) . Hm D1075 as well as the full-length receptor induced c-myc transcription, whereas the EGFR in accordance with reported data did not (Figure 7c) . Strikingly, activation of Hm D1006, which can trigger mitotic signalling did not lead to a signi®cant upregulation of c-myc ( Figure  7c ). Thus, induction of pim-1 by Hm D1006 (Figure 7a ) may be sucient to induce DNA-synthesis.
MAP kinase activation is needed for complete anti-apoptotic signalling
Since Hm D1006 activated STAT5 signalling and triggered DNA-synthesis but was not sucient to activate MAP kinase signalling and suppress apoptosis, we wondered if MAP kinase activation was needed for the mediation of anti-apoptotic signals. Therefore, we expressed the HM D1006 receptor in the Ba/F3 cell line (Figure 8b,c) , indicating that additional MAPK activation is essential for anti-apoptotic signalling triggered by Hm D1006. The fact, however, that the EGFR although activating MAPK (see Figure  2b ) is insucient in suppressing apoptosis suggests (see Figure 1c ) that both STAT5 and MAPK are needed for complete anti-apoptotic signalling mediated by receptors of the EGFR family.
Discussion
Homodimers of the mrk kinase act as potent growth factor receptors
To investigate the role of STAT5 in the signal transduction of the melanoma inducing Xmrk receptor we used Ba/F3 cells as a sensitive system to measure mitogenic as well as anti-apoptotic signalling. We found that homodimers of the mrk kinase eciently trigger long-term growth in Ba/F3 cells, which lack endogenous expression of all EGFR family members (Riese et al., 1995) . Strikingly, all other members of the EGFR family are insucient to trigger mitogenic as well as anti-apoptotic signals and thus long-term growth in these cells as homodimers (Riese et al., 1996a,b; Shibuya et al., 1992) . Nevertheless, heterodimers of the EGFR and HER2 after stimulation with either EGF or TGFalpha are able to mediate long-term growth in Ba/F3 cells (Riese et al., 1996b) indicating that both receptors together induce sucient signalling.
Constitutive expression of TGFalpha, inducing stimulation of EGFR homodimers as well as EGFR/ HER2 heterodimers is a late event in human melanoma development resulting in autocrine growth signalling (Rodeck et al., 1991) . Noteworthy, whereas expression of HER2 is found in melanocytes as well as in melanoma (Peris et al., 1991) , the expression level of EGFR correlates with melanoma progression and is not found in melanocytes (Rodeck et al., 1991) . This together with the fact that melanocytes transformed by neu but lacking EGFR expression are not tumorigenic (Dotto et al., 1989) may re¯ect that in human melanoma receptors of the EGFR family trigger cell transformation as heterodimers. In this respect it is striking that in general cellular transformation induced by EGFR/HER2 heterodimers is much stronger than of homodimers or even dependent on the presence of both receptors (DiGiovanna et al., 1998; Kokai et al., 1989; O'Rourke et al., 1997; Zhang et al., 1996) . As seen in Ba/F3 cells this situation may be mimicked by homodimers of the Xmrk receptor in ®sh melanoma, thus making it a unique model receptor to investigate the involvement of RTKs in melanoma formation.
Interactions of the intracellular part of Xmrk with MAPK and STAT5
Analysis of dierent HER-mrk receptor mutants in Ba/ F3 cells helped to characterize substrate interactions within the intracellular receptor domain. Activation of the MAPK cascade was dependent on the ®rst 100 aminoacids of the mrk carboxyterminus present in Hm D1075, since the truncated receptor Hm D1006 was incapable to induce phosphorylation of MAPK. This ®nding is in accordance with the identi®cation of Tyr-1033 (YVNQ) in the Xmrk carboxyterminus as GRB2 binding site (Wellbrock and Schartl, 1999) .
We found that STAT5 constitutively binds to the intracellular part of the Xmrk receptor in a phosphotyrosine independent way. Moreover the truncated Hm D1006 receptor, which only possesses an intact kinase domain bound to and induced activation of STAT5 and expression of the STAT5 target genes cis, pim-1 and bcl-x. Phosphorylated tyrosine residues have been identi®ed as being essential for an interaction and subsequent activation of STAT5 not only for cytokine receptors (Damen et al., 1995; Mayr et al., 1998) but also for the PDGF receptor (Paukku et al., 2000) . However, for the EGFR type receptors data are somewhat contradictory. Deletion of EGFR carboxyterminal tyrosine residues that conform to the consensus YXXQ led to the loss of STAT activation in NIH 3T3 cells (Coer and Kruijer, 1995) . On the other hand an EGFR mutant lacking all carboxyterminal tyrosine phosphorylation sites is still able to induce activation of STAT1, 3 and 5 in NR6 ®broblasts (David et al., 1996) . Our data suggest that STAT5 binds directly to the mrk kinase domain. However, carboxyterminal residues may stabilize the interaction leading to an enhanced STAT5 activation as seen with the full-length receptor. Strikingly, Hm D1006, in contrast to its activation of STAT5, was insucient to activate either STAT1 or STAT3 (data not shown), which indicates that for activation of these STAT factors carboxyterminal tyrosine residues are essential. A similar situation was found for the common cytokine receptor subunit gp 130, where STAT1 and STAT3 bind to speci®c phosphotyrosine residues, whereas STAT5 binds to the JH2 domain of the constitutively associated janus kinase JAK1 (Fujitani et al., 1997) . Moreover, in cotransfection assays JAK2 was able to activate STAT5 not only in a receptor independent way, but also independently of the presence of the SH2 domain of STAT5 . This points to a direct activation of the STAT protein by the JAK kinase. Since the Xmrk kinase domain possesses high similarity to the JH2 domain of JAKs, STAT5 might directly interact with the intracellular part of the receptor without involvement of its SH2 domain and mainly the STAT5 carboxyterminus containing its regulatory tyrosine is bound by the catalytic domain of the HER-mrk receptor.
Thus, our data point to a new mechanism of activation of STAT5 by RTKs, in which direct association leads to direct phosphorylation of STAT5 after receptor stimulation and dimerization.
Role of STAT5 in proliferation and survival
Activation of STAT5 by the mrk kinase correlated with mitogenic signalling re¯ected by the cell cycle progression induced by Hm D1006 (see Figure 9) . Moreover, the fact that c-myc, known to contribute to proliferation rather than survival signals in Ba/F3 cells (Kinoshita et al., 1995; Leverrier et al., 1997; Nosaka et al., 1999; Shibuya et al., 1992) was not upregulated by Hm D1006 although this receptor induced mitogenic signalling, suggests that upregulation of pim-1 expression by STAT5 may be sucient to trigger cell cycle progression.
Activation of STAT5 alone, however, was not sucient to suppress apoptosis, since the Hm D1006 receptor activating STAT5 but not MAPK was unable to trigger cell survival (see Figure 9) . Interestingly, MAPK was found to be essential for mediation of survival signals by dierent cytokine receptors (Kinoshita et al., 1995 (Kinoshita et al., , 1997 Leverrier et al., 1997) . On the other hand MAPK was activated by the EGFR, which nevertheless was inecient to suppress apoptosis. However, the fact that constitutive activation of MAPK signalling in BaF Hm D1006DStu cells enabled the Hm D1006 receptor to triggered suppression of apoptosis suggests that for RTKs of the EGFR family a cooperation between STAT5 and MAPK signalling is needed for ecient survival in this cell system. Considering that IL-3 induced bcl-x expression is signi®cantly reduced in Ba/F3 cells expressing a dominant negative MAPK (Leverrier et al., 1997) , this indicates that MAPK signals contribute to STAT5 directed gene expression and may explain why in BaF Hm D1006 cells reduced bcl-x expression was found. Thus STAT5, by induction of its target genes pim-1 and bcl-x plays a potent role in HER-mrk signalling in Ba/F3 cells. However, additional activation of MAPK is essential for complete cell survival and proliferation triggered by the mrk kinase in this cell system (see Figure 9 ).
Since STAT5 activation leads to the induction of genes involved in controlling cell proliferation and survival it is discussed to be one of the major STAT proteins involved in promoting oncogenesis (Bowman et al., 2000) . Accordingly, constitutive STAT5 activation is found in a variety of transformed hematopoietic cells as well as in melanoma cells of Xiphophorus (Wellbrock et al., 1998) . However, STAT proteins such as STAT1 and 2 on the other hand are playing an important role in the anti-proliferative function of various cytokine receptors acting also on melanoma cells (Lazar-Molnar et al., 2000) . Remarkably, for interferons and also for TGF-beta, another melanoma growth inhibitory cytokine, it was found in Ba/F3 cells that they can exert their anti-proliferative function by inhibiting the JAK/STAT5 pathway (Jaster et al., 1999) . Thus, STAT5 may act as a counter-player to the inhibitory function of other STAT family members and constitutive activation of STAT5 as detected in Xiphophorus melanoma cells may contribute to enhanced proliferation and anti-apoptotic signalling found such cells.
Material and methods
Cells
Ba/F3 cells (Palacios and Steinmetz, 1985) and Ba/F3 derived cell lines were cultured in RPMI 1640 containing 5% supernatant of mIL-3 expressing cells. Stable transfectants were generated by electroporation as described (Wellbrock et al., 1998) . A whole cell ELISA assay (Lischke et al., 1996) using a monoclonal antibody (mAb 108.1) against the extracellular receptor part was employed to identify clones expressing similar amounts of the respective receptor versions.
Construction of receptor mutants
The HER-mrk-expression plasmid (Prk5 Hm) is driven by the CMV promoter (Wittbrodt et al., 1992) . Hm DKin was constructed by partial digestion with Acc I and religation of the Prk5 Hm, removing a 651 bp fragment containing nearly the complete kinase domain. To construct the Hm D702, Hm D1006, Hm D1075 and Hm D1096 plasmids the Prk5 vector was enlarged by the polylinker and translation-stop-codon of pGEX-KG. The corresponding fragment was isolated from pGEX-KG by digestion with AatII (blunted by Klenow) and BamHI. It was ligated into the HindIII (blunted by Klenow) and BamHI digested vector Prk5, generating Prk5 G(S). Prk5 Hm D702 contains a 2214 bp XbaI ± StuI fragment. Prk5 Hm D1006 was constructed by transferring a 3125 bp XbaI ± SalI fragment of Prk5 Hm into Prk5 G(S). Hm D1075 was constructed by cloning a 3332 bp XbaI ± EcoRV fragment of Prk5 Hm into Prk5 G(S). For construction of Prk5 Hm D1153 HER-mrk derived oligonucleotides, containing a translation-stop-codon and a new restriction site for HindIII were used for PCR. The ampli®ed DNA fragment was digested with SalI-HindIII and ligated into Prk5 Hm D1006 SalI ± HindIII.
Thymidine incorporation assay and long-term growth 4610 4 cells per well of a 96-well plate were treated with IL-3 (5% sup.) or EGF (50 ng/ml) and 3 H-thymidine incorporation was measured as described (Wellbrock et al., 1998) . For long-term growth analysis cells were seeded at 1610 5 cells/ml and diluted to the same concentration every 2 ± 3 days. Cells were either kept in the presence of IL-3 (5% sup.) or EGF (50 ng/ml) and counted after trypan-blue staining.
DNA-fragmentation
1610
6 cells were washed twice in PBS and then incubated in medium without IL-3 for 2 h followed by incubation with either 5% IL-3 supernatant or 50 ng/ml EGF for 20 h. Cells were washed in PBS, lysed in 500 ml lysis buer (0.2% SDS, 100 mM EDTA, 200 mM NaCl) complemented with fresh Proteinase K (100 mg/ml) and then incubated at 808C for 1 h. Figure 9 Model for mitogenic and survival signalling of HERmrk in Ba/F3 cells. The mrk kinase domain (black box) present in Hm D1006 is sucient to bind and activate STAT5, but carboxyterminal residues contribute to enhanced activation. Activation of MAPK, however, is dependent on carboxyterminal sequences. The kinase can be activated by Hm D1075, since in this receptor mutant the described GRB2 binding-site YVNQ is present. Whereas STAT5 promotes mitogenic signalling and contributes to anti-apoptotic signalling additional MAPK activation completes cell survival and proliferation triggered by the mrk kinase After 10 min of centrifugation the DNA was recovered by phenol/chloroform extraction and ethanol precipitation. The DNA was dissolved in water, complemented with RNase A (500 mg/ml) and gel loading buer and analysed on 1.8% agarose gels.
Antibodies
Anti-ptyr 5E.2 (Fendly et al., 1990 ) and mAb 108.1 (Lax et al., 1989) are mouse monoclonal antibodies and were kindly provided by A Ullrich. Polyclonal rabbit anti-STAT5b (C-17), anti STAT1(E-23) and anti-ERK2(C-14) were from Santa Cruz Biotechnology, USA. Rabbit polyclonal antibcl-x was from Transduction Laboratories, USA. Rabbit polyclonal anti-phosphoso Akt and anti-Akt were from New England Biolabs, USA, anti-phospho-MAPK clone D12 was from Nanotools, Germany.
Immunoprecipitations and Western blotting
After stimulation, cells were rinsed twice with cold PBS and lysed in 1% Triton buer as described (Wellbrock et al., 1998) . Lysates either were directly analysed or incubated with the indicated antibodies and protein A-Sepharose for at least 1 h at 48C. Proteins were analysed by Western blotting as described (Wellbrock et al., 1998) .
Immunofluorescence analyis
10
5 untreated or stimulated cells were suspended in 500 ml of ice-cold PBS and spun onto slides at 2206g for 3 min using a cytospin device (Hettich). Cells were consecutively ®xed for at least 10 min at 7208C in methanol and for 2 min at 7208C in acetone. The ®xed cells were then blocked with 1% BSA in PBS for 20 min at room temperature, washed three times with PBS and incubated with anti-STAT5 serum (5 mg/ ml) for 60 min. After washing another incubation with Cy3-conjugated anti-rabbit IgG (Dianova; 7.5 mg/ml) for 60 min followed. Cells were embedded in DAPI containing mounting medium (Vectashield, Vector).
Preparation of cell extracts and STAT5 DNA-binding
Whole-cell extracts were prepared from 3610 7 cells by four freeze-thaw cycles in low salt lysis buer as described (Wellbrock et al., 1998) . Extracts were incubated with 100 mg of M280-Streptavidin Dynabeads (Dynal, Germany) carrying either a STAT5 binding-site (5'-GATCAGATTTC-TAGGAATTCAATCC-3'; (Pallard et al., 1995) or a high anity STAT1/STAT3 binding-site (5'-GATCCATTTCCC-GTAAATCGTCG-3'; (Zhong et al., 1994) ). Bound proteins were eluated and analysed on a Western blot as described (Wellbrock et al., 1998) .
RT ± PCR analysis
RNA was prepared using TRIZOL reagent (Gibco, Germany). First strand cDNA synthesis was performed by using 1 mg total RNA and random hexanucleotides (0.5 mM). The respective genes were ampli®ed with a number of cycles where ampli®cation was still linear. The following primers were used: cis 5'-CTGCTGTGCATAGCCAAGACGTTC-3' and 5'-CAGAGTTGGAAGGGGTACTGTCGG-3'; pim-1 5'-ACGTGGAGAAGGACCGGATTTCC-3' and 5'-GATG-TTTTCGTCCTTGATGTCGC-3'; gapdh 5'-CGGAGTCAA-CGGATTTGGTCGTAT-3' and 5'-AGCCTTCTCCATGG-TGGTGAAGAC-3'.
Northern blot analysis
RNA was prepared using TRIZOL reagent (Gibco, Germany). Twenty mg of total RNA was blotted onto Hybond-N nylon membranes (Amersham, UK). Filters were hybridized with a 32 P-labelled probe which was generated by random priming with a 32 P-dCTP. The probes used were a 900 bp human bcl-x fragment and a mouse myc EST clone (Accession Number AA008076; Resource Centre, MPI Berlin). Prehybridization and hybridization were carried out at 428C in 35 or 50% formamide respectively.
